ALBIREO Trademark

Trademark Overview


On Tuesday, November 6, 2007, a trademark application was filed for ALBIREO with the United States Patent and Trademark Office. The USPTO has given the ALBIREO trademark a serial number of 79046388. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Tuesday, November 7, 2017. This trademark is owned by Albireo AB c/o AstraZeneca AB, Legal Dept.. The ALBIREO trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for human use in the prevention and treatment of gynaecological diseases and disorders, cardiovascular including dyslipidemia, atherosclerosis and cholesterol lowering diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders, hepatico- pancreatico biliary- diseases, musculoskeletal diseases and disorders; migraines, pain, inflammation and inflammatory diseases and disorders; autoimmune diseases, metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral, parasitic and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; haemolytic diseases and disorders; oncological and malignant diseases and disorders; postoperative adhesions; bone diseases and disorders; ophthalmologic disorders and diseases; dermatological diso...

Surgical, medical and veterinary apparatus and instruments, namely, upper gastrointestinal endoscopes/colonoscopes with stents, injection devices for intragastric/intrarectal injection/infusion, dilation balloons with drug delivery systems, targeted delivery devices to specific parts of the gastrointestinal tract using ingested capsules with remote control release mechanism

Scientific consulting services and research and design in the field of the development of pharmaceutical and medical preparations and products
albireo

General Information


Serial Number79046388
Word MarkALBIREO
Filing DateTuesday, November 6, 2007
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateTuesday, November 7, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use in the prevention and treatment of gynaecological diseases and disorders, cardiovascular including dyslipidemia, atherosclerosis and cholesterol lowering diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders, hepatico- pancreatico biliary- diseases, musculoskeletal diseases and disorders; migraines, pain, inflammation and inflammatory diseases and disorders; autoimmune diseases, metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral, parasitic and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; haemolytic diseases and disorders; oncological and malignant diseases and disorders; postoperative adhesions; bone diseases and disorders; ophthalmologic disorders and diseases; dermatological disorders and diseases; ophthalmologic preparations; tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; skin and tissue repair and smoking cessation; Sanitary preparations for medical purposes; Veterinary pharmaceutical preparations for the prevention and treatment of gynaccological diseases and disorders, cardiovascular including dyslipidemia, atherosclerosis and cholesterol lowering diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders; hepatico- pancreatico- biliary- diseases, musculoskeletal diseases and disorders; pain, inflammation and inflammatory diseases and disorders; autoimmune diseases, metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral, parasitic and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction, haemolytic diseases and disorders; oncological and malignant diseases and disorders; postoperative adhesions; bone diseases and disorders; ophthalmologic disorders and diseases; dermatological disorders and diseases; ophthalmologic preparations; tooth decay, gingivitis, halitosis and periodontal disease; skin and tissue repair; all of the foregoing for treating felines, canines, bovines, porcines, equines, llamas, rabbits, rodents, birds, ferrets, poultry, goats and sheep
Goods and ServicesSurgical, medical and veterinary apparatus and instruments, namely, upper gastrointestinal endoscopes/colonoscopes with stents, injection devices for intragastric/intrarectal injection/infusion, dilation balloons with drug delivery systems, targeted delivery devices to specific parts of the gastrointestinal tract using ingested capsules with remote control release mechanism
Goods and ServicesScientific consulting services and research and design in the field of the development of pharmaceutical and medical preparations and products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, November 7, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, November 7, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, November 7, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlbireo AB c/o AstraZeneca AB, Legal Dept.
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressSE-413 46 GÖTEBORG
SE

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressSE-431 35 Mölndal
SE

Trademark Events


Event DateEvent Description
Saturday, June 2, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, June 1, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, March 22, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, July 30, 2011FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 11, 2011FINAL DISPOSITION NOTICE SENT TO IB
Saturday, July 9, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, July 9, 2010ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, July 9, 2010ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, December 4, 2009NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, December 4, 2009FINAL REFUSAL E-MAILED
Friday, December 4, 2009FINAL REFUSAL WRITTEN
Thursday, September 17, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 17, 2009LETTER OF SUSPENSION E-MAILED
Thursday, September 17, 2009SUSPENSION LETTER WRITTEN
Wednesday, September 16, 2009AMENDMENT FROM APPLICANT ENTERED
Wednesday, September 16, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 11, 2009PAPER RECEIVED
Thursday, August 6, 2009NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, May 14, 2009NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, May 14, 2009NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, March 11, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 11, 2009NON-FINAL ACTION E-MAILED
Wednesday, March 11, 2009NON-FINAL ACTION WRITTEN
Tuesday, March 3, 2009AMENDMENT FROM APPLICANT ENTERED
Tuesday, March 3, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 27, 2009PAPER RECEIVED
Wednesday, January 14, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, December 13, 2008CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, August 27, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 27, 2008NON-FINAL ACTION E-MAILED
Wednesday, August 27, 2008NON-FINAL ACTION WRITTEN
Wednesday, August 20, 2008AMENDMENT FROM APPLICANT ENTERED
Wednesday, August 20, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 20, 2008ASSIGNED TO LIE
Thursday, August 14, 2008PAPER RECEIVED
Thursday, April 10, 2008CHANGE OF OWNER RECEIVED FROM IB
Friday, March 14, 2008REFUSAL PROCESSED BY IB
Saturday, February 23, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 22, 2008REFUSAL PROCESSED BY MPU
Friday, February 22, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 21, 2008NON-FINAL ACTION WRITTEN
Wednesday, February 20, 2008ASSIGNED TO EXAMINER
Friday, December 14, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, December 13, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB